Boston Scientific, a leading medical technology company, has recently reported the findings of its AVANT GUARD clinical trial on the...
DA-1726 IND Application Submitted to FDA for Phase 1 Clinical Trial in Obesity Treatment Obesity has become a global epidemic,...
Successful Pivotal Study Demonstrates Efficacy of Cytokinetics’ Heart Drug Aficamten Cytokinetics, a biopharmaceutical company focused on developing innovative treatments for...
Cu-64 SAR-bisPSMA Administered to First Patient in Phase III Prostate Cancer Trial, Reports Drugs.com MedNews Prostate cancer is one of...
Drugs.com MedNews Reports a Historic Surge in Americans Opting for Obamacare In recent years, the healthcare landscape in the United...
UniQure’s Gene Therapy for Huntington’s Disease Continues to Face Investor Skepticism UniQure, a leading gene therapy company, has been working...
Azura Ophthalmics, a leading ophthalmic company, recently announced positive results from the Phase 2 clinical trial of their novel drug,...
Title: Promising Results from ORSERDU® Combination Studies in ER+, HER2- Metastatic Breast Cancer Patients Presented at the 2023 San Antonio...
The First CRISPR Medicine: An Oral History of Uncompromising Standards In recent years, the field of gene editing has witnessed...
Frontotemporal dementia (FTD) is a devastating neurodegenerative disorder that primarily affects the frontal and temporal lobes of the brain, leading...
Positive New Data from Phase 1 Study of Breast Cancer Vaccine Presented by Anixa Biosciences and Cleveland Clinic Breast cancer...
The Food and Drug Administration (FDA) and Syapse, a leading precision medicine company, have recently announced a collaboration aimed at...
From On-the-Job Teacher Training to Owning Her Own Classroom: The Journey of a Paraprofessional Paraprofessionals play a crucial role in...
The Potential Implications of Phase II Obesity Results for Altimmune and Pfizer Obesity is a global health crisis that affects...
Stoke Therapeutics, a biotechnology company focused on developing treatments for severe genetic diseases, recently presented its latest findings on children...
